Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Hematologic Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 8 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neoplasms 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Motor Activity 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Colonic Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Uveal Melanoma 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Opioid-Related Disorders 1 Neuroblastoma 1 Neoplastic Cells, Circulating 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Inflammation 1 Hodgkin Disease 1 Hepatic Veno-Occlusive Disease 1 HPV Positive Oropharyngeal Squamous Cell Carcinoma 1 Fibrosis 1

Interventions

Ipilimumab 25 Nivolumab 19 pembrolizumab 11 incomplete Freund's adjuvant 10 Cyclophosphamide 9 Melphalan 8 Interleukin-2 8 sargramostim 7 MART-1 Antigen 7 CTLA-4 Antigen 7 Temozolomide 6 Ranibizumab 6 tebentafusp 5 montanide ISA 51 5 Sunitinib 5 Radiosurgery 5 Dacarbazine 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Carboplatin 4 Blood Specimen Collection 4 Biopsy 4 Bevacizumab 4 trametinib 3 sotrastaurin 3 fludarabine phosphate 3 fludarabine 3 binimetinib 3 Vorinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04424719 2025-09-03

SALOME

Institut Curie

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡